{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:26:00Z","timestamp":1793946360173,"version":"4.8.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jim.2026.114062","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:56:49Z","timestamp":1779145009000},"page":"114062","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel methods for neural IgG characterization and validation in autoimmune neurologic disorders"],"prefix":"10.1016","volume":"548","author":[{"given":"Michael","family":"Gilligan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McKeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4158","key":"10.1016\/j.jim.2026.114062_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.186.4158.55","article-title":"Serum globulin in myasthenia gravis: inhibition of alpha-bungarotoxin binding to acetylcholine receptors","volume":"186","author":"Almon","year":"1974","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.jim.2026.114062_bb0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0022-510X(93)90176-Y","article-title":"Posterior uveitis, paraneoplastic encephalomyelitis and auto-antibodies reacting with developmental protein of brain and retina","volume":"117","author":"Antoine","year":"1993","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jim.2026.114062_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2022.926570","article-title":"Palmitoylation-regulated interactions of the pseudokinase calmodulin kinase-like vesicle-associated with membranes and Arc\/Arg3.1","volume":"14","author":"Barylko","year":"2022","journal-title":"Front. Synaptic Neurosci."},{"issue":"18","key":"10.1016\/j.jim.2026.114062_bb0020","doi-asserted-by":"crossref","first-page":"e1677","DOI":"10.1212\/WNL.0000000000006435","article-title":"Paraneoplastic neuronal intermediate filament autoimmunity","volume":"91","author":"Basal","year":"2018","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.jim.2026.114062_bb0025","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/mds.29991","article-title":"Autoimmune neurobeachin cerebellar ataxia","volume":"39","author":"Basal","year":"2024","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.jim.2026.114062_bb0030","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1212\/01.WNL.0000038352.01415.CE","article-title":"Cerebellar degeneration and autoimmunity to zinc-finger proteins of the cerebellum","volume":"59","author":"Bataller","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0035","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.20238","article-title":"Carbonic anhydrase-related protein VIII: autoantigen in paraneoplastic cerebellar degeneration","volume":"56","author":"Bataller","year":"2004","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/jnnp.14.2.59","article-title":"Subacute cortical cerebellar degeneration and its relation to carcinoma","volume":"14","author":"Brain","year":"1951","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/brain\/83.3.357","article-title":"Subacute encephalitis of later adult life. Mainly affecting the limbic areas","volume":"83","author":"Brierley","year":"1960","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0050","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0896-6273(93)90077-5","article-title":"Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system","volume":"11","author":"Buckanovich","year":"1993","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.1097","article-title":"Potassium channel antibodies in two patients with reversible limbic encephalitis","volume":"50","author":"Buckley","year":"2001","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0060","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jalm\/jfab127","article-title":"Clinical sensitivity, specificity, and predictive value of neural antibody testing for autoimmune encephalitis","volume":"7","author":"Budhram","year":"2022","journal-title":"J. Appl. Lab. Med."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0065","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200216","article-title":"Membrane proteome-wide screening of autoantibodies in CIDP using human cell microarray technology","volume":"11","author":"Caballero-Avila","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jim.2026.114062_bb0070","first-page":"854","article-title":"Toxische Klienhirnatophie bei Brustkrebs: Zertenoblatt for die gesamate","volume":"53","author":"Casper","year":"1929","journal-title":"J. Neurol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jaut.2009.12.004","article-title":"Peripherin-IgG association with neurologic and endocrine autoimmunity","volume":"34","author":"Chamberlain","year":"2010","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.1127","article-title":"ANNA-3 anti-neuronal nuclear antibody: marker of lung cancer-related autoimmunity","volume":"50","author":"Chan","year":"2001","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/brain\/91.3.481","article-title":"\u201cLimbic encephalitis\u201d and its association with carcinoma","volume":"91","author":"Corsellis","year":"1968","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.jim.2026.114062_bb0090","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1212\/WNL.36.9.1163","article-title":"Partial characterization of the Purkinje cell antigens in paraneoplastic cerebellar degeneration","volume":"36","author":"Cunningham","year":"1986","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.jim.2026.114062_bb0100","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"16","key":"10.1016\/j.jim.2026.114062_bb0105","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMra023009","article-title":"Paraneoplastic syndromes involving the nervous system","volume":"349","author":"Darnell","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0110","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1084\/jem.178.6.2219","article-title":"The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer","volume":"178","author":"De Camilli","year":"1993","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0115","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000701","article-title":"Diagnostic yield of commercial immunodots to diagnose paraneoplastic neurologic syndromes","volume":"7","author":"Dechelotte","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.0000000000003586","article-title":"Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies","volume":"88","author":"Do","year":"2017","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12311-018-0987-5","article-title":"TRIM9 and TRIM67 are new targets in paraneoplastic cerebellar degeneration","volume":"18","author":"Do","year":"2019","journal-title":"Cerebellum"},{"issue":"Pt 10","key":"10.1016\/j.jim.2026.114062_bb0130","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/brain\/aww189","article-title":"Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy","volume":"139","author":"Doppler","year":"2016","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.jim.2026.114062_bb0135","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1073\/pnas.84.13.4552","article-title":"Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration","volume":"84","author":"Dropcho","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0140","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jim.2026.114062_bb0145","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jamaneurol.2020.2231","article-title":"Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic Kelch-like protein-11 encephalitis","volume":"77","author":"Dubey","year":"2020","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.jim.2026.114062_bb0150","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ana.26050","article-title":"Leucine zipper 4 autoantibody: a novel germ cell tumor and paraneoplastic biomarker","volume":"89","author":"Dubey","year":"2021","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jim.2026.114062_bb0155","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/jamaneurol.2022.1357","article-title":"Identification of caveolae-associated protein 4 autoantibodies as a biomarker of immune-mediated rippling muscle disease in adults","volume":"79","author":"Dubey","year":"2022","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.jim.2026.114062_bb0160","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jim.2026.114062_bb0170","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJM199302253280805","article-title":"Autoantibodies to a 128-kd synaptic protein in three women with the stiff-man syndrome and breast cancer","volume":"328","author":"Folli","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/2472555219897567","article-title":"New advances in cell microarray technology to expand applications in target deconvolution and off-target screening","volume":"25","author":"Freeth","year":"2020","journal-title":"SLAS Discov."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0180","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000011","article-title":"AQP4 autoantibody assay performance in clinical laboratory service","volume":"1","author":"Fryer","year":"2014","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","article-title":"Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients","volume":"82","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0190","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ana.24872","article-title":"Microtubule-associated protein 1B: novel paraneoplastic biomarker","volume":"81","author":"Gadoth","year":"2017","journal-title":"Ann. Neurol."},{"issue":"7","key":"10.1016\/j.jim.2026.114062_bb0195","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1007\/s00415-022-10973-8","article-title":"The importance of tissue-based assay in the diagnosis of autoimmune encephalitis","volume":"269","author":"Gadoth","year":"2022","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0200","first-page":"67","article-title":"Paraneoplastic neurologic disorders","volume":"23","author":"Gilligan","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0205","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ana.26943","article-title":"Paraneoplastic calmodulin kinase-like vesicle-associated protein (CAMKV) autoimmune encephalitis","volume":"96","author":"Gilligan","year":"2024","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jim.2026.114062_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2024.110746","article-title":"Autoimmune central nervous system disorders: antibody testing and its clinical utility","volume":"126","author":"Gilligan","year":"2024","journal-title":"Clin. Biochem."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0215","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acn3.52273","article-title":"Autoimmune brainstem encephalitis: clinical associations, outcomes, and proposed diagnostic criteria","volume":"12","author":"Gilligan","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0220","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/acn3.70238","article-title":"Insights into the antigenic repertoire of unclassified synaptic antibodies","volume":"13","author":"Gilligan","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0225","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1212\/WNL.35.4.538","article-title":"Neuronal antinuclear antibody in sensory neuronopathy from lung cancer","volume":"35","author":"Graus","year":"1985","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0230","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0002-9343(86)90047-1","article-title":"Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor","volume":"80","author":"Graus","year":"1986","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.jim.2026.114062_bb0235","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jim.2026.114062_bb0240","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","article-title":"Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes","volume":"165","author":"Graus","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0245","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0250","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0255","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200353","article-title":"Anti-IgLON5 disease 10 years later: what we know and what we do not know","volume":"12","author":"Graus","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0260","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1212\/WNL.0000000000013087","article-title":"Glial fibrillary acidic protein autoimmunity: a French cohort study","volume":"98","author":"Gravier-Dumonceau","year":"2022","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/brain\/57.2.161","article-title":"Subacute spino-cerebellar degeneration occurring in elderly patients","volume":"57","author":"Greenfield","year":"1934","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0270","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/ana.410140603","article-title":"Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma","volume":"14","author":"Greenlee","year":"1983","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0275","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","article-title":"Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study","volume":"13","author":"Gresa-Arribas","year":"2014","journal-title":"Lancet Neurol."},{"issue":"24","key":"10.1016\/j.jim.2026.114062_bb0280","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","article-title":"Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development","volume":"86","author":"Gresa-Arribas","year":"2016","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0285","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1212\/WNL.0000000000012240","article-title":"Autoimmune Septin-5 disease presenting as spinocerebellar Ataxia and nystagmus","volume":"97","author":"Herrero San Martin","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0290","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/ana.26482","article-title":"Septin-5 and -7-IgGs: neurologic, serologic, and pathophysiologic characteristics","volume":"92","author":"Hinson","year":"2022","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0295","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaneurol.2013.1955","article-title":"Patient with homer-3 antibodies and cerebellitis","volume":"70","author":"Hoftberger","year":"2013","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.jim.2026.114062_bb0300","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000385","article-title":"IgLON5 antibody: neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"5","key":"10.1016\/j.jim.2026.114062_bb0305","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000474","article-title":"Autoimmune septin-5 cerebellar ataxia","volume":"5","author":"Honorat","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.jim.2026.114062_bb0310","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1212\/WNL.0000000000008061","article-title":"Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG","volume":"93","author":"Honorat","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jim.2026.114062_bb0315","doi-asserted-by":"crossref","first-page":"1260358","DOI":"10.3389\/fneur.2023.1260358","article-title":"Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide","volume":"14","author":"Hor","year":"2023","journal-title":"Front. Neurol."},{"issue":"8","key":"10.1016\/j.jim.2026.114062_bb0320","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/pmic.201000206","article-title":"Identification of autoantibody biomarkers for primary Sjogren\u2019s syndrome using protein microarrays","volume":"11","author":"Hu","year":"2011","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1074\/mcp.M116.061002","article-title":"Identification of novel biomarkers for Behcet disease diagnosis using human proteome microarray approach","volume":"16","author":"Hu","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"issue":"16","key":"10.1016\/j.jim.2026.114062_bb0340","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1212\/01.wnl.0000327606.50322.f0","article-title":"Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody","volume":"71","author":"Hutchinson","year":"2008","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jim.2026.114062_bb0345","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins Leucine-rich, glioma inactivated 1 protein and Contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jim.2026.114062_bb0350","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-7-21","article-title":"A new Purkinje cell antibody (anti-Ca) associated with subacute cerebellar ataxia: immunological characterization","volume":"7","author":"Jarius","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jim.2026.114062_bb0355","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12974-014-0206-3","article-title":"Antibodies to the inositol 1,4,5-trisphosphate receptor type 1 (ITPR1) in cerebellar ataxia","volume":"11","author":"Jarius","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0360","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001162","article-title":"Novel cell-based assay for Alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic ganglionopathy","volume":"9","author":"Karagiorgou","year":"2022","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0365","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00415-025-13039-7","article-title":"Exploring autoantigens in autoimmune limbic encephalitis using phage immunoprecipitation sequencing","volume":"272","author":"Kherbek","year":"2025","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0370","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0375","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"issue":"18","key":"10.1016\/j.jim.2026.114062_bb0380","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.0b013e3182364a44","article-title":"Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0385","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000916","article-title":"Seizure-related 6 homolog like 2 autoimmunity: neurologic syndrome and antibody effects","volume":"8","author":"Landa","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0390","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nbt.1856","article-title":"Autoantigen discovery with a synthetic human peptidome","volume":"29","author":"Larman","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0395","first-page":"423","article-title":"The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane","volume":"66","author":"Lebar","year":"1986","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0400","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0896-8411(89)90149-2","article-title":"Chronic experimental autoimmune encephalomyelitis in the guinea pig. Presence of anti-M2 antibodies in central nervous system tissue and the possible role of M2 autoantigen in the induction of the disease","volume":"2","author":"Lebar","year":"1989","journal-title":"J. Autoimmun."},{"issue":"22","key":"10.1016\/j.jim.2026.114062_bb0405","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1056\/NEJM199506013322203","article-title":"Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes","volume":"332","author":"Lennon","year":"1995","journal-title":"N. Engl. J. Med."},{"issue":"9451","key":"10.1016\/j.jim.2026.114062_bb0410","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0415","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jim.2026.114062_bb0420","article-title":"Applications of protein microarrays in biomarker discovery for autoimmune diseases","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.jim.2026.114062_bb0425","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1212\/WNL.0000000000004356","article-title":"Emerging subspecialties in neurology: autoimmune neurology","volume":"89","author":"Lopez-Chiriboga","year":"2017","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0430","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer","volume":"29","author":"Luque","year":"1991","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0435","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMoa1816721","article-title":"Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis","volume":"381","author":"Mandel-Brehm","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.jim.2026.114062_bb0440","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1007\/s00415-024-12680-y","article-title":"Long-term outcomes in antibody-negative autoimmune encephalitis: a retrospective study","volume":"271","author":"Mangioris","year":"2024","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.jim.2026.114062_bb0445","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1084\/jem.20071053","article-title":"Neurofascin as a novel target for autoantibody-mediated axonal injury","volume":"204","author":"Mathey","year":"2007","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0450","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1212\/CON.0000000000001447","article-title":"Overview and diagnostic approach in autoimmune neurology","volume":"30","author":"McKeon","year":"2024","journal-title":"Continuum (Minneap Minn)"},{"issue":"10","key":"10.1016\/j.jim.2026.114062_bb0455","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/archneurol.2011.128","article-title":"Purkinje cell cytoplasmic autoantibody type 1 accompaniments: the cerebellum and beyond","volume":"68","author":"McKeon","year":"2011","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0460","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/mus.23774","article-title":"Striational antibodies in a paraneoplastic context","volume":"47","author":"McKeon","year":"2013","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0465","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/acn3.51284","article-title":"Neuronal intermediate filament IgGs in CSF: autoimmune axonopathy biomarkers","volume":"8","author":"McKeon","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.jim.2026.114062_bb0470","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200145","article-title":"Utility of protein microarrays for detection of classified and novel antibodies in autoimmune neurologic disease","volume":"10","author":"McKeon","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jim.2026.114062_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/acn3.70378","article-title":"GAD65 antibody ELISA with extended reportable range: validation and guidance for neurological practice","author":"McKeon","year":"2026","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"9","key":"10.1016\/j.jim.2026.114062_bb0480","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41596-018-0025-6","article-title":"PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes","volume":"13","author":"Mohan","year":"2018","journal-title":"Nat. Protoc."},{"issue":"9","key":"10.1016\/j.jim.2026.114062_bb0485","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/brain\/awab153","article-title":"Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis","volume":"144","author":"Muniz-Castrillo","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.jim.2026.114062_bb0490","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1499810","article-title":"AI-enhanced profiling of phage-display-identified anti-TIM3 and anti-TIGIT novel antibodies","volume":"16","author":"Musnier","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.jim.2026.114062_bb0495","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023112","article-title":"Diagnosis of Alzheimer\u2019s disease based on disease-specific autoantibody profiles in human sera","volume":"6","author":"Nagele","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jim.2026.114062_bb0500","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1196\/annals.1254.022","article-title":"Autoimmune disorders of neuronal potassium channels","volume":"998","author":"Newsom-Davis","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0505","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa059","article-title":"High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display","volume":"2","author":"O\u2019Donovan","year":"2020","journal-title":"Brain Commun."},{"issue":"24","key":"10.1016\/j.jim.2026.114062_bb0510","doi-asserted-by":"crossref","first-page":"8151","DOI":"10.1523\/JNEUROSCI.4415-13.2014","article-title":"Identification and characterization of GABA(a) receptor autoantibodies in autoimmune encephalitis","volume":"34","author":"Ohkawa","year":"2014","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0515","doi-asserted-by":"crossref","DOI":"10.1212\/CPJ.0000000000200151","article-title":"Autoimmune encephalitis criteria in clinical practice","volume":"13","author":"Orozco","year":"2023","journal-title":"Neurol. Clin. Pract."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0520","first-page":"18","article-title":"Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes","volume":"33","author":"Ortega Suero","year":"2018","journal-title":"Neurologia (Engl. Ed.)"},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0525","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/acn3.52254","article-title":"Phenotypic and oncological insights in ANNA1 autoimmunity: age stratification and biomarker analysis","volume":"12","author":"Paramasivan","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"4088","key":"10.1016\/j.jim.2026.114062_bb0530","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.jim.2026.114062_bb0535","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in Aquaporin-4-positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0540","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.23794","article-title":"Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Querol","year":"2013","journal-title":"Ann. Neurol."},{"issue":"Pt 11","key":"10.1016\/j.jim.2026.114062_bb0545","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/122.11.2047","article-title":"Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study","volume":"122","author":"Reindl","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.jim.2026.114062_bb0550","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1243946","article-title":"Identification of SKOR2 IgG as a novel biomarker of paraneoplastic neurologic syndrome","volume":"14","author":"Rezk","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jim.2026.114062_bb0555","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.3389\/fimmu.2020.01482","article-title":"The diagnostic value of onconeural antibodies depends on how they are tested","volume":"11","author":"Ruiz-Garc\u00eda","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0560","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000658","article-title":"Paraneoplastic cerebellar ataxia and antibodies to metabotropic glutamate receptor 2","volume":"7","author":"Ruiz-Garcia","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"12","key":"10.1016\/j.jim.2026.114062_bb0565","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0570","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","article-title":"A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study","volume":"13","author":"Sabater","year":"2014","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0575","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/acn3.52310","article-title":"Real-world clinical experience with serum MOG and AQP4 antibody testing by live versus fixed cell-based assay","volume":"12","author":"Said","year":"2025","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jim.2026.114062_bb0580","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01447","article-title":"A spectrum of neural autoantigens, newly identified by histo-immunoprecipitation, mass spectrometry, and recombinant cell-based indirect immunofluorescence","volume":"9","author":"Scharf","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0585","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2009.10.031","article-title":"A new paraneoplastic encephalomyelitis autoantibody reactive with the axon initial segment","volume":"467","author":"Shams\u2019ili","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0590","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000612","article-title":"Neurochondrin neurological autoimmunity","volume":"6","author":"Shelly","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jim.2026.114062_bb0595","first-page":"6","volume":"6","author":"Shelly","year":"2019","journal-title":"Neurochondrin neurological autoimmunity. Neurol Neuroimmunol Neuroinflamm."},{"issue":"24","key":"10.1016\/j.jim.2026.114062_bb0600","doi-asserted-by":"crossref","first-page":"e2966","DOI":"10.1212\/WNL.0000000000012050","article-title":"Clinical utility of striational antibodies in paraneoplastic and myasthenia gravis paraneoplastic panels","volume":"96","author":"Shelly","year":"2021","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jim.2026.114062_bb0605","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410380505","article-title":"Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves","volume":"38","author":"Shillito","year":"1995","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0610","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor","volume":"342","author":"Sillevis Smitt","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.jim.2026.114062_bb0615","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0620","doi-asserted-by":"crossref","DOI":"10.1002\/0471140864.ps2701s72","article-title":"Overview of protein microarrays","volume":"27","author":"Sutandy","year":"2013","journal-title":"Curr. Protoc. Protein Sci."},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0625","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1074\/mcp.R120.001936","article-title":"Developments and applications of functional protein microarrays","volume":"19","author":"Syu","year":"2020","journal-title":"Mol. Cell. Proteomics"},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0630","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0092-8674(91)90184-Z","article-title":"HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal","volume":"67","author":"Szabo","year":"1991","journal-title":"Cell"},{"issue":"1\u20132","key":"10.1016\/j.jim.2026.114062_bb0635","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jneuroim.2007.03.015","article-title":"Adenylate kinase 5 autoimmunity in treatment refractory limbic encephalitis","volume":"186","author":"Tuzun","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jim.2026.114062_bb0640","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2016.00037","article-title":"Detection and characterization of autoantibodies to neuronal cell-surface antigens in the central nervous system","volume":"9","author":"van Coevorden-Hameete","year":"2016","journal-title":"Front. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.jim.2026.114062_bb0645","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/acn3.396","article-title":"Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes","volume":"4","author":"van Coevorden-Hameete","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.jim.2026.114062_bb0650","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1093\/brain\/awz094","article-title":"The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies","volume":"142","author":"van Coevorden-Hameete","year":"2019","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.jim.2026.114062_bb0655","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time","volume":"15","author":"van Sonderen","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jim.2026.114062_bb0660","article-title":"Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq","volume":"11","author":"Vazquez","year":"2022","journal-title":"bioRxiv. elife"},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0665","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200003)47:3<297::AID-ANA4>3.0.CO;2-4","article-title":"New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity","volume":"47","author":"Vernino","year":"2000","journal-title":"Ann. Neurol."},{"issue":"21","key":"10.1016\/j.jim.2026.114062_bb0670","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody profiles and neurological correlations of thymoma","volume":"10","author":"Vernino","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.jim.2026.114062_bb0675","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jim.2026.114062_bb0680","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ana.20614","article-title":"Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma","volume":"58","author":"Vitaliani","year":"2005","journal-title":"Ann. Neurol."},{"issue":"23","key":"10.1016\/j.jim.2026.114062_bb0685","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJM199906103402303","article-title":"A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer","volume":"340","author":"Voltz","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2026.114062_bb0690","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1265797","article-title":"CDR2 and CDR2L line blot performance in PCA-1\/anti-Yo paraneoplastic autoimmunity","volume":"14","author":"Vorasoot","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0695","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/jamaneurol.2024.4763","article-title":"Novel meningoencephalomyelitis associated with vimentin IgG autoantibodies","volume":"82","author":"Wan","year":"2025","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jim.2026.114062_bb0700","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/B978-0-444-63432-0.00009-8","article-title":"Detection methods for neural autoantibodies","volume":"133","author":"Waters","year":"2016","journal-title":"Handb. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.jim.2026.114062_bb0705","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1136\/jnnp-2015-312601","article-title":"Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica","volume":"87","author":"Waters","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.jim.2026.114062_bb0710","doi-asserted-by":"crossref","first-page":"e1250","DOI":"10.1212\/WNL.0000000000007096","article-title":"A multicenter comparison of MOG-IgG cell-based assays","volume":"92","author":"Waters","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.jim.2026.114062_bb0715","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-823912-4.00010-4","article-title":"Evolution of methods to detect paraneoplastic antibodies","volume":"200","author":"Waters","year":"2024","journal-title":"Handb. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0720","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/brain\/88.3.529","article-title":"Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy","volume":"88","author":"Wilkinson","year":"1965","journal-title":"Brain"},{"key":"10.1016\/j.jim.2026.114062_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1220295","article-title":"Case report: anti Septin-5-encephalitis as a treatable cause of cerebellar ataxia and psychiatric symptoms","volume":"14","author":"Wischmann","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.jim.2026.114062_bb0730","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s00415-013-7134-5","article-title":"Identification of anti-Sez6l2 antibody in a patient with cerebellar ataxia and retinopathy","volume":"261","author":"Yaguchi","year":"2014","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jim.2026.114062_bb0735","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity","volume":"49","author":"Yu","year":"2001","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.jim.2026.114062_bb0740","doi-asserted-by":"crossref","first-page":"e815","DOI":"10.1212\/WNL.0000000000007971","article-title":"Phosphodiesterase 10A IgG: a novel biomarker of paraneoplastic neurologic autoimmunity","volume":"93","author":"Zekeridou","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jim.2026.114062_bb0745","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/ana.26320","article-title":"Anti-neuronal nuclear antibody 3 autoimmunity targets dachshund homolog 1","volume":"91","author":"Zekeridou","year":"2022","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.jim.2026.114062_bb0750","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1212\/01.wnl.0000251308.79366.f9","article-title":"Homer 3 autoimmunity in subacute idiopathic cerebellar ataxia","volume":"68","author":"Zuliani","year":"2007","journal-title":"Neurology"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175926000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175926000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:29:46Z","timestamp":1793942986000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175926000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":148,"alternative-id":["S0022175926000384"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2026.114062","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel methods for neural IgG characterization and validation in autoimmune neurologic disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2026.114062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114062"}}